Dr. Jason Westin on Combination Targeted Therapy Prior to Chemotherapy for DLBCL

Leggi l'articolo originale


Cancer Network spoke with Jason Westin, MD, of MD Anderson Cancer Center, about the Smart Start trial, which showed that a combination of targeted therapy prior to chemotherapy proved to be effective in patients with DLBCL.

Lascia un commento